Amphastar Pharmaceuticals Inc.

AMPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$24.76

+$0.28 (+1.14%)

Sep 22, 2026, 2:01 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ALKS Alkermes plc	N/A
ANGO AngioDynamics	N/A
ANIP ANI Pharmaceuticals	N/A
COLL Collegium Pharmaceutical	N/A
PCRX Pacira BioSciences	N/A
RDY Dr. Reddy's Laboratories	0.65%

Dividend Rankings ➞

Recent News

5 months ago / seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2026 Earnings Call Transcript
5 months ago / zacks.com
Compared to Estimates, Amphastar (AMPH) Q1 Earnings: A Look at Key Metrics
5 months ago / zacks.com
Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates
5 months ago / accessnewswire.com
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
5 months ago / accessnewswire.com
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
7 months ago / zacks.com
Compared to Estimates, Amphastar (AMPH) Q4 Earnings: A Look at Key Metrics
7 months ago / seekingalpha.com
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2025 Earnings Call Transcript
7 months ago / zacks.com
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
7 months ago / accessnewswire.com
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025
7 months ago / accessnewswire.com
Amphastar Announces FDA Approval for Ipratropium Bromide HFA